ANGIEX (U.S. Trademark Serial Number 86948315) is a United States trademark of Angiex, Inc.. The goods and services include: Pharmaceutical research and development; Development of pharmaceutical preparations, medicines, and diagnostics; Research in the field of drugs and diagnostic preparations for detecting, imaging and treating cancer; Conducting early evaluations in the field of new pharmaceuticals and diagnostics preparations . The correspondent is KEITH TOMS, ESQUIRE of MCCARTER & ENGLISH LLP.
This trademark was filed on March 22, 2016 as United States Trademark Application Serial Number 86948315. The trademark application was registered on July 04, 2017 as U.S. Trademark Registration 5237897.
Trademark PTO Status History
July 04, 2022 – COURTESY REMINDER – SEC. 8 (6-YR) E-MAILED
July 04, 2017 – REGISTERED-PRINCIPAL REGISTER
June 01, 2017 – NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 31, 2017 – ALLOWED PRINCIPAL REGISTER – SOU ACCEPTED
May 18, 2017 – TEAS/EMAIL CORRESPONDENCE ENTERED
May 18, 2017 – CORRESPONDENCE RECEIVED IN LAW OFFICE
May 09, 2017 – TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 01, 2017 – TEAS EXTENSION RECEIVED
View full trademark status information at USPTO
Ownership History
Angiex, Inc.
Angiex, Inc.
Angiex, Inc.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.